You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib
|
---|---|
Published in |
European Journal of Cancer (1965), June 2019
|
DOI | 10.1016/j.ejca.2019.05.002 |
Pubmed ID | |
Authors |
Karl Lewis, Axel Hauschild, James Larkin, Antoni Ribas, Keith T. Flaherty, Grant A. McArthur, Brigitte Dréno, Edward McKenna, Qian Zhu, Yong Mun, Paolo A. Ascierto |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 2 | 67% |
United States | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 12 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 2 | 17% |
Researcher | 2 | 17% |
Professor | 1 | 8% |
Student > Ph. D. Student | 1 | 8% |
Unknown | 6 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 25% |
Nursing and Health Professions | 1 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
Computer Science | 1 | 8% |
Chemistry | 1 | 8% |
Other | 0 | 0% |
Unknown | 5 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2019.
All research outputs
#15,115,524
of 25,411,814 outputs
Outputs from European Journal of Cancer (1965)
#5,049
of 6,876 outputs
Outputs of similar age
#188,908
of 366,737 outputs
Outputs of similar age from European Journal of Cancer (1965)
#50
of 75 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,876 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,737 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.